Abstract

The Anatomical RecordVolume 304, Issue 12 p. 2895-2895 RetractionFree Access Retraction This article retracts the following: RETRACTED: CircFBXW7 alleviates glioma progression through regulating miR-23a-3p/PTEN axis Zhi-Gang Gao, Peng Yang, Jie Huang, Yong-Qiang Ding, Volume 304Issue 2The Anatomical Record pages: 279-290 First Published online: June 17, 2020 First published: 28 October 2021 https://doi.org/10.1002/ar.24807AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat CircFBXW7 alleviates glioma progression through regulating miR-23a-3p/PTEN axis, by Zhi-Gang GAO, Peng YANG, Jie HUANG, and Yong-Qiang DING. The above article, published in The Anatomical Record (DOI: 10.1002/ar.24410) is retracted by the Editor-in-Chief, Dr. Heather Smith, with notification to the American Association for Anatomy and Wiley Periodicals LLC. The decision is the result of an investigation based on concerns raised by a third party. The authors were not available for comments. Based on the investigation that revealed issues of scientific integrity in the data, the editors consider the conclusions of the paper substantially compromised. REFERENCE Gao, Z. G., Yang, P., Huang, J., & Ding, Y. Q. (2021 Feb). CircFBXW7 alleviates glioma progression through regulating miR-23a-3p/PTEN axis. Anat Rec (Hoboken), 304(2), 279– 290. https://doi.org/10.1002/ar.24410Wiley Online LibraryCASPubMedGoogle Scholar Volume304, Issue12December 2021Pages 2895-2895 ReferencesRelatedInformation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call